openPR Logo
Press release

Dextrose Injection Market - Size, Share, Outlook, and Forecast till 2026

Dextrose is a form of glucose, which is widely used as an artificial sweetener. Dextrose 5% in water is used as a solution for injections to be administered into a vein through an IV to replace lost fluids and provide carbohydrates to the body.

Dextrose is widely used to treat hypoglycemia, insulin shock, and dehydration. Dextrose has nutritional applications and is used as a nutritional support for patients who are unable to eat due to an illness and injury. Increasing prevalence of hypoglycemia in turn, is expected to boost growth of the dextrose injections market.

Fructose is a natural sweetener found in fruits, while dextrose is artificially made for enhancing the taste of varied food products such as honey and sweets. Increasing demand for honey and honey-based products in turn, is increasing the demand for dextrose.

Injections of dextrose are associate severe burning, pain, and swelling around the needled area, furthermore, warmth, redness, oozing, or bleeding where the IV is placed, as well as other health issues such as fever and an ongoing cough. These health issues in turn, pose as major factors hampering growth of the dextrose injections market.

These injections could cause anxiety, sweating, pale skin, severe shortness of breath, wheezing, pain, fast or uneven heart rate, while less severe side effects include upset stomach and swelling in hands or feet. This also poses as a major restraint for growth of the dextrose injections market.

Dextrose Injections USP are sterile, nonpyrogenic, and contain no bacteriostatic or antimicrobial agents. These injections are used for adults and pediatric patients as sources of calories and water for hydration. Dosage depends upon age, weight, and clinical condition. The wide category of usage of these injections are responsible for the rapid growth of the dextrose injections market.

Weifang Shengtai supplied Kelun Pharmaceutical, a pharmaceutical group has 16 subsidiaries with 10 thousand tons of dextrose monohydrate injection grade. Such large scale production by increasing number of manufacturers in turn, is boosting growth of the dextrose injections market.

In June 2018 Amphastar Pharmaceuticals, Inc., announced approval from the U.S. Food and Drug Administration (FDA) for Isoproterenol Hydrochloride Injection, USP 0.2mg/mL, 1mL and 0.2mg/mL, 5mL single dose vial. Isoproterenol Hydrochloride is indicated for multiple uses including for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. Amphastar’s newly approved product was determined by the FDA to be therapeutically equivalent to Isuprel (Isoproterenol Hydrochloride Injection) sold in the U.S. by Valeant Pharmaceuticals.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

1001 4th Ave,
#3200
Seattle, WA 98154,
U.S

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dextrose Injection Market - Size, Share, Outlook, and Forecast till 2026 here

News-ID: 1212743 • Views: 157

More Releases for Pharmaceutical

Pharmaceutical Packaging Equipment Market
The Global Pharmaceutical Packaging Equipment Market is expected to grow from USD 62235.24 Millions in 2018 to USD 98562.24 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.78%. Get Free Sample: https://reports.valuates.com/request/sample/360I-Auto-4F48/Global_Pharmaceutical_Packaging_Equipment "Growing pharmaceutical industry in emerging economies is one of the factors largely attributing to the growth of the Global Pharmaceutical Packaging Equipment Market " View Full Report: https://reports.valuates.com/market-reports/360I-Auto-4F48/global-pharmaceutical-packaging The factors attributing to the growth of the
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market